July 24, 2017
UPCOMING /Recent Talks

Modern Imaging Techniques in the Diagnosis and Management of Prostate Cancer 

with Dr. Antonio Carlos Westphalen 
July 27th, 2017. 8PM EST RSVP
Multiparametric MRI (mpMRI) is considered as a game-changer in prostate cancer treatment and management.  Our prostate cancer panel of Mike Scott, Tony Crispino, Allen Edel, and Joel Nowak is talking to Dr. Antonio Carlos Westphalen about the current roles of MRI and mpMRI in the diagnosis and management of prostate cancer. The panel will touch upon current roles of older forms of bone scanning and CT as well as discuss the evolving roles of newer imaging techniques in the diagnosis and management of high risk and metastatic prostate cancer. Issues on access to high quality imaging and role of the expert uro-radiologist in diagnosis and management of prostate cancer are some of the other aspects that will be covered in this discussion. 
Dr. Antonio Carlos Westphalen 
Mike Scott 
Allen Edel 
Joel T. Nowak
Tony Crispino 
Novel Technologies to Check Male Fertility Status 
with Dr. Jamin Brahmbhatt
July 14th, 2017. 1PM EST LISTEN
Male factor infertility accounts for 50% of total cases of troubled conception. Unfortunately, male infertility is not as promptly reported as female infertility which is tracked by Society for Assisted Reproductive Technology database. One key reason for under-reporting of male infertility is lesser availability of means of tracking it. When it comes to fertility testing, where women have quite a few over the counter products, men have very few options. Curetalks male fertility advocates and panelists Kristen Darcy, Sara Naab, and Jonathan Boldt are talking to Dr. Jamin Brahmbhatt to learn about new options available for men and also discuss novel advancements in techniques to check male fertility status.
Dr. Jamin Brahmbhatt 
Kristen Darcy 
Sara Naab
Jonathan Boldt 
Shweta Mishra 
The MMRF Precision Medicine Model - How Close to Myeloma Cure Are We
with Anne Quinn Young
June 29th, 2017. 5PM EST LISTEN
The MMRF has built a unique model that provides the only end-to-end solution in cancer research. This model is based on three inter-related pillars fueled by data generation and integration; collaboration and discovery, and accelerating clinical trials. Integrating this model with precision medicine MMRF aims to get closer to finding a cure for multiple myeloma. We are talking to Anne Quinn Young of MMRF to learn about the details of this initiative and also discuss the results and other developments of the CoMMpass trial. Panelists
Anne Quinn Young 
Gary Petersen 
Cynthia Chmielewski
Jack Aiello
Matt Goldman
For any of the talks dial-in to 718-664-6574 to participate and ask a question LIVE On-Air! Only 50 callers permitted at one time so HURRY!
Our Picks
TrialX Editor